Presence faecal lactoferrin in patients with Clostridium difficile infection – own observations
Marcin Hawro | Krzysztof Tomasiewicz | Robert Pleśniak | Marta Musz-Kawecka
Management of invasive fungal infections in the critically ill non-neutropenic patients – recent recommendations
Mirosław Czuczwar | Jolanta Komarnicka | Jarosław Woroń | Wiktor Sułkowski | Alicja Bartkowska-Śniatkowska
Antifungal activity of selected anticancer drugs
Jakub Król | Urszula Nawrot | Marzenna Bartoszewicz
Fidaxomycin in the treatment of Clostridium difficile infection
Grażyna Rydzewska
Use of clindamycin in therapy of oral cavity infections
Beata Sulik-Tyszka | Justyna Cieślik | Agnieszka Bogusławska-Kapała | Izabela Strużycka | Marta Wróblewska
Symptomatic uncomplicated diverticular disease of the colon – the current state of knowledge and principles of treatment
Maria Kłopocka | Ariel Liebert
Risk factors related to the recognition and prevention of healthcare-associated infections
Anna Ziółko
Prevention of vertical transmission of HIV from the perspective of the gynecologist
Agnieszka Wroblewska | Justyna D. Kowalska
Use of clindamycin before dental procedure in immunocompromised patients – case report
Izabela Strużycka | Agnieszka Bogusławska-Kapała | Przemysław Orzechowski | Beata Sulik-Tyszka | Justyna Cieślik | Marta Wróblewska